Meihua International Medical Technologies Co., Ltd. (MHUA)
USD 0.33
(14.45%)
USD 0.33
(14.45%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 11.62 Million USD | 86.22% |
| 2022 | 6.24 Million USD | -70.2% |
| 2021 | 20.94 Million USD | 10.0% |
| 2020 | 19.04 Million USD | 23.42% |
| 2019 | 15.43 Million USD | -0.3% |
| 2018 | 15.47 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 2.35 Million USD | 0.0% |
| 2024 Q1 | 2.35 Million USD | 3.36% |
| 2023 Q4 | 2.28 Million USD | 0.0% |
| 2023 Q1 | 3.53 Million USD | 1232.03% |
| 2023 FY | 11.62 Million USD | 86.22% |
| 2023 Q3 | 2.28 Million USD | -67.69% |
| 2023 Q2 | 7.06 Million USD | 100.0% |
| 2022 Q2 | 6.55 Million USD | 100.0% |
| 2022 FY | 6.24 Million USD | -70.2% |
| 2022 Q1 | 3.27 Million USD | -44.72% |
| 2022 Q4 | -311.91 Thousand USD | -100.0% |
| 2022 Q3 | -155.95 Thousand USD | -102.38% |
| 2021 Q4 | 5.92 Million USD | 0.0% |
| 2021 Q3 | 5.92 Million USD | 30.41% |
| 2021 Q2 | 4.54 Million USD | 0.0% |
| 2021 Q1 | 4.54 Million USD | 2.77% |
| 2021 FY | 20.94 Million USD | 10.0% |
| 2020 Q2 | 5.09 Million USD | 0.0% |
| 2020 FY | 19.04 Million USD | 23.42% |
| 2020 Q4 | 4.42 Million USD | -0.0% |
| 2020 Q3 | 4.42 Million USD | -13.24% |
| 2020 Q1 | 5.09 Million USD | 94.1% |
| 2019 Q1 | 5.08 Million USD | 0.0% |
| 2019 Q4 | 2.62 Million USD | 0.0% |
| 2019 Q3 | 2.62 Million USD | -48.38% |
| 2019 Q2 | 5.08 Million USD | 0.0% |
| 2019 FY | 15.43 Million USD | -0.3% |
| 2018 FY | 15.47 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 118.359% |
| AngioDynamics, Inc. | -184.34 Million USD | 106.306% |
| AtriCure, Inc. | -30.43 Million USD | 138.194% |
| Avinger, Inc. | -18.32 Million USD | 163.458% |
| Azenta, Inc. | -14.25 Million USD | 181.542% |
| BioLife Solutions, Inc. | -66.42 Million USD | 117.501% |
| The Cooper Companies, Inc. | 294.2 Million USD | 96.048% |
| Daxor Corporation | 280.64 Thousand USD | -4042.466% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 176.493% |
| Femasys Inc. | -14.24 Million USD | 181.598% |
| GlucoTrack, Inc. | -7.09 Million USD | 263.807% |
| Harvard Bioscience, Inc. | -3.41 Million USD | 440.422% |
| Hologic, Inc. | 789.5 Million USD | 98.527% |
| ICU Medical, Inc. | -29.65 Million USD | 139.202% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 99.353% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 184.603% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 61.384% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 274.466% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 274.466% |
| Masimo Corporation | 81.5 Million USD | 85.736% |
| Microbot Medical Inc. | -10.74 Million USD | 208.244% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 87.686% |
| Nephros, Inc. | -1.57 Million USD | 838.122% |
| NovoCure Limited | -207.04 Million USD | 105.615% |
| NEXGEL, Inc. | -3.15 Million USD | 468.243% |
| NEXGEL, Inc. | -3.15 Million USD | 468.243% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 112.261% |
| OraSure Technologies, Inc. | 53.65 Million USD | 78.333% |
| Pro-Dex, Inc. | 2.12 Million USD | -446.564% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 127.542% |
| Predictive Oncology Inc. | -13.98 Million USD | 183.134% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | 493.898% |
| QuidelOrtho Corporation | -10.1 Million USD | 215.103% |
| Repligen Corporation | 41.57 Million USD | 72.039% |
| Sanara MedTech Inc. | -4.3 Million USD | 370.158% |
| STAAR Surgical Company | 21.34 Million USD | 45.541% |
| Sharps Technology, Inc. | -9.84 Million USD | 218.125% |
| Utah Medical Products, Inc. | 16.63 Million USD | 30.115% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 108.807% |
| Jin Medical International Ltd. | 2.87 Million USD | -303.909% |